Friday, February 25, 2022
8:30 PM – 9:30 PM Local Time
Sheraton Phoenix Downtown
340 North Third Street
Phoenix, AZ 85004
Meeting Room: Phoenix Ballroom C, Third Level
Program Features
- iPads provided to all attendees to enhance learning experience and enable real-time Q&A
- Create your own personalized poster
- Interactive case-based learning environment
- Animated Simulation Treatment Challenge
Faculty
Mario Castro, MD, MPH
Chief, Pulmonary, Critical Care and Sleep Medicine
Vice Chair for Clinical and Translational Research
Director, Frontiers: University of Kansas Clinical
& Translational Science Institute
Director, Rainbow Clinical Trials Science Unit
University of Kansas School of Medicine
Kansas City, KS
Diego J Maselli, MD, FCCP
Associate Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Severe Asthma Program
University Health System
San Antonio, TX
Target Audience
This activity is designed to meet the educational needs of allergists, immunologists, and other health care providers involved in the care of patients with moderate-to-severe asthma.
Learning Objectives
After completing the activity, learners should be better able to:
- Utilize biomarkers to identify asthma phenotypes and endotypes and to personalize the selection of therapy for patients with moderate-to-severe disease
- Differentiate between uncontrolled and severe asthma and identify patients who require step-up therapy to reduce asthma exacerbations and oral corticosteroid use
- Develop evidence-based treatment plans for patients with moderate-to-severe asthma that consider exacerbation risks, comorbidities, and quality of life
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the virtual event at [email protected]
